To sell your existing private-label beauty products in the EU, UK or US you do not need a new formula in most cases — you need a legal representative established in that market, a safety and technical file that already exists in the right format, and a re-made label. The single biggest cause of delay is not regulation itself but discovering, months in, that your OEM manufacturer never compiled the documents your new market assumes you already hold. Before you commit to a distributor or a trade show, ask your factory for the safety assessment, the GMP evidence and the full ingredient breakdown in writing, and see what actually arrives.
Key takeaways
- Every one of these markets requires a person or company established locally — an EU Responsible Person, a UK Responsible Person, or a US “responsible person” named on the label under MoCRA. This is a legal role with liability, not a mailing address.
- The document set, not the product, is the bottleneck. The EU and UK both require a Product Information File containing a Cosmetic Product Safety Report before the product is placed on the market; a factory that has never exported there may have none of it.
- Do not let a distributor hold your notification by default. If the notification or registration sits in your distributor’s name, changing distributors can mean re-notifying, re-labelling and losing shelf continuity.
- Some categories change pathway entirely. A sunscreen is a cosmetic in the EU, UK and ASEAN but an over-the-counter drug in the United States — the same bottle cannot simply be shipped across.
- Budget 3 to 6 months from “documents complete” to first legal sale, and add a re-print cycle for artwork. Elapsed time is driven by how quickly your manufacturer answers, not by the regulator.
What actually changes when you sell the same product in a new market?
Four things change when a product crosses a regulatory border: who is legally accountable, which authority has to be told, what evidence must exist on file, and what the label says. The product inside the jar usually stays the same. That is why brand owners under-estimate the work — nothing about manufacturing changes, so it feels like a shipping problem, and it is actually a paperwork and accountability problem.
The formula does sometimes have to change. Ingredient restrictions are set market by market: the EU maintains banned and restricted substance lists in the annexes to Regulation (EC) No 1223/2009, searchable through the European Commission’s CosIng database, and a preservative or UV filter permitted at one concentration in your home market may be capped lower or prohibited in Europe. The EU and UK also prohibit placing on the market cosmetics whose finished product or ingredients were tested on animals for cosmetic purposes — a rule that can disqualify an ingredient sourced through a supplier who cannot confirm its testing history. Ask your manufacturer to screen the full formula against the destination market’s annexes before you spend money on artwork or a distributor agreement.
Here is the practical map for the four markets most private-label brands ask about. Treat the timings as planning ranges observed in ordinary cases, not guarantees — a file with gaps takes as long as it takes to fill them.
| Market | Who must be established there | Notification / listing route | Core safety file required | What changes on the label | Typical elapsed time from complete file |
|---|---|---|---|---|---|
| European Union | Responsible Person (RP) established in the EU, named on the pack | Cosmetic Product Notification Portal (CPNP), before placing on market | Product Information File incl. Cosmetic Product Safety Report (Annex I) | RP name and EU address, INCI list, nominal content, durability or period-after-opening, batch number, country of origin, member-state language(s) | 6–12 weeks |
| Great Britain | UK Responsible Person established in the UK | Submit Cosmetic Product Notifications (SCPN) service | Product Information File incl. safety report, held at the UK RP’s address | UK RP name and UK address, English labelling; a GB product needs its own notification even if already in CPNP | 6–12 weeks |
| United States | The “responsible person” whose name appears on the label, plus a registered manufacturing facility | Facility registration and product listing with FDA under MoCRA | Records adequate to substantiate safety, kept by the responsible person | US-format ingredient declaration, net quantity, distributor statement, warnings; drug labelling if the product is an OTC drug | 4–10 weeks |
| ASEAN member states | A company established in that member state holds the notification | National notification under the ASEAN Cosmetic Directive (e.g. HSA in Singapore, NPRA in Malaysia) | Product Information File in ASEAN format, produced on request | Local notification holder’s details, ASEAN labelling particulars, local-language requirements in some states | 4–10 weeks |
Two entries in that table are worth stressing. First, a CPNP notification does not cover Great Britain and a GB notification does not cover the EU — since the UK left the EU regime these are two separate systems with two separate representatives, and Northern Ireland continues to follow the EU rules. Brands routinely budget for one and get billed for two. Second, the United States has no pre-market approval for ordinary cosmetics, which is often read as “no rules”; it is not. MoCRA added mandatory facility registration, product listing, adverse-event reporting and safety-substantiation record-keeping, and the responsible person named on the label carries those duties.
Who has to be your legal representative in the EU, UK and US?
In the EU and UK the Responsible Person is a company established in that territory that takes legal responsibility for the product’s compliance, holds the Product Information File, is named on the pack and is the party an enforcement authority contacts. In the US, MoCRA attaches its duties to the responsible person whose name already appears on the label under existing labelling rules. In all three cases someone other than your factory is carrying the risk — and that someone is either you, a service provider you pay, or your distributor.
Those three options are genuinely different, and the choice is harder to reverse than it looks:
- Your own local entity. Full control, and the notification stays yours if a commercial relationship ends. Costs the most up front and means you carry the compliance duty in-house, which requires someone who can actually read a safety report.
- A specialist RP service provider. The common route for indie brands. You pay per product per year, they review the file, submit the notification and act as the contact point. Control stays with you. The service is only as good as the file you give them, and a competent provider will refuse to notify an incomplete dossier — which is a feature, not an obstruction.
- Your importer or distributor acting as RP. Cheapest, fastest, and the option most likely to cause pain later. If your distributor is the RP and the notification holder, they control your market access. Ending the relationship can mean appointing a new RP, transferring or re-submitting the notification and re-printing packaging that carries the old RP’s name and address.
If a distributor offers to “handle all the registration” at no cost, read that as a commercial term, not a favour. At minimum, negotiate in writing that the Product Information File and safety report belong to you, that the notification will be transferred to a party you nominate on termination, and that you receive a copy of every submission. This is the same principle as protecting your formula and moulds in the manufacturing agreement, and it belongs in the contract alongside the clauses covered in our guidance on what an OEM cosmetics contract should contain.
Which documents does your manufacturer have to supply, and when?
Roughly three quarters of the market-entry file has to come from the factory, not from you — and that is the part you do not control. A brand owner can write a marketing plan in a weekend; nobody can write a stability report retrospectively. The order in which you request these documents therefore decides your launch date.
The table below lists what an EU or UK Responsible Person will ask for, who actually produces each item, and the objection you should expect to hear from a factory that has not exported to that market before. The last column is not cynicism — it is the fastest way to tell an experienced export partner from an inexperienced one.
| Document | Who produces it | Needed for | Typical lead time | Common objection you will hear |
|---|---|---|---|---|
| Full quantitative formula (all ingredients, % w/w, INCI names, CAS numbers) | Manufacturer | EU, UK, ASEAN, US safety substantiation | Days — if they agree | “The formula is confidential.” Resolve with a confidentiality agreement or direct factory-to-assessor disclosure. |
| Raw-material specifications, CoAs and supplier declarations | Manufacturer, via ingredient suppliers | Product Information File | 2–6 weeks | “We will send a summary.” A summary is not a specification; assessors need the source documents. |
| Animal-testing declarations for the finished product and ingredients | Manufacturer and ingredient suppliers | EU, UK | 2–6 weeks | “Nobody asks for this.” The EU and UK do. |
| Stability and packaging-compatibility reports | Manufacturer or contracted lab | Shelf life, durability marking, safety report | Weeks to months if not already run | “This formula has been sold for years.” History is not a report. |
| Preservative-efficacy (challenge) test to ISO 11930 | Contracted microbiology lab | Microbiological safety section of the safety report | 6–10 weeks | “It is included in QC.” Routine QC is not a challenge test. |
| GMP evidence — ISO 22716 certificate or an audit-ready statement | Manufacturer | EU, UK; expected by most RP providers | Days if certified | “We follow GMP.” Ask to see the certificate and its scope. |
| Cosmetic Product Safety Report signed by a qualified assessor | Safety assessor (may be arranged by the factory or your RP) | EU, UK — mandatory before market | 3–8 weeks after the file is complete | “We can provide our own certificate.” It must be a qualified assessor’s report. |
| Claim-support data (SPF, clinical, dermatological) | Contracted lab | Any market where the claim is printed | 6–16 weeks | “All our customers use this claim.” The claim must be substantiated for your product. |
Two of these deserve separate reading before you negotiate. The safety report is the gatekeeping document for Europe — our explainer on what a Cosmetic Product Safety Report contains and who signs it sets out the Annex I structure and which parts your factory has to supply. And the underlying laboratory work is the long pole: if the pre-production test panel was never run properly, no amount of budget compresses a real-time stability study or a challenge test. Where a factory holds a current ISO 22716 certificate and an organised documentation system, this whole stage typically takes weeks; where it does not, it can take a year or quietly never finish.
When you are requesting all of this at once, do it as a single written list with deadlines rather than a trickle of messages. Our checklist of documents to request from a cosmetics manufacturer works as the base list; for an export project, add the animal-testing declarations and the country-specific claim files. If your current factory cannot produce this set, that is useful information about whether they are the right partner for an export phase at all — the manufacturers listed in our OEM and private-label manufacturer directory vary enormously on export documentation maturity, and it is a fair question to ask on the first call.
What does market entry cost, and how long does it take?
Expect the compliance layer of an EU or UK launch to cost somewhere in the low thousands per product for the first product and materially less for each additional variant in the same range, because the safety assessment can often reuse shared data. The figures below are indicative planning ranges, not quotations — they vary by product complexity, by how much testing already exists, and by provider. Use them to sanity-check a proposal, not as a budget you can hold anyone to.
| Cost line | Indicative range per product | Notes |
|---|---|---|
| Safety assessment / CPSR (EU or UK) | Low hundreds to low thousands | Cheaper per unit across a range sharing a formula base; a novel or high-risk formula costs more |
| Responsible Person service, annual | Low hundreds per product per year | Often discounted per additional SKU; check what is excluded (label review, complaint handling) |
| Missing laboratory work | Highly variable | Challenge testing and stability are the usual gaps; claim studies such as SPF cost the most |
| Notification submission | No fee in the EU and UK systems; FDA registration and listing carry no user fee under MoCRA | Your cost is the preparation, not the filing |
| Artwork rework and re-print | Design time plus new plates or cylinders | Each market’s mandatory particulars differ; a shared multi-market label saves money only if planned from the start |
| Duties, shipping and landed cost | Depends on Incoterms and HS classification | Agree who clears customs before you quote a wholesale price |
The label rework is the line most often forgotten. A market change is a full artwork cycle — new responsible-person details, a re-checked ingredient declaration, sometimes a new language and a different net-quantity format. If you have never run that cycle, our walkthrough of getting cosmetic packaging artwork print-ready covers the approval stages and where they usually stall, and the companion packaging and label requirements checklist lists the mandatory particulars by market. Plan the label as a multi-market layout from the beginning if you can: a panel designed with space for a second address and a second language costs nothing extra at artwork stage and saves a re-print later. Getting the compliance elements right the first time is much cheaper than a recall, which is why it is worth reading up on setting cosmetic labels up for compliance before briefing a designer.
On price, resist copying your home-market retail price into the new market. The landed cost is different, the retail structure is different and the distributor takes a margin that a direct-to-consumer model does not. Rebuild the number from the bottom using the method in our guide to pricing private-label beauty products, and settle the shipping and duty responsibility explicitly — the Incoterms and deposit questions covered in our guide to payment terms in cosmetics OEM apply to the export leg as much as to the factory invoice.
Which market should you enter first, and what usually goes wrong?
Enter the market where you already have demand and a route to the customer, not the market with the easiest paperwork. Compliance cost is a one-off you can plan; a market where nobody is asking for your product is a recurring loss. That said, the practical ordering for most small brands is: an ASEAN member state or the United States first if your product is an ordinary cosmetic and you have a buyer, then the EU or UK once the safety file exists — because the European file, once built, is the most transferable asset you will own. It satisfies the hardest reviewer, and much of it can be reused elsewhere.
Three failure patterns account for most stalled launches:
- The category was misclassified. Sunscreen is the classic case: an OTC drug in the United States, a cosmetic in the EU, UK and ASEAN. Products making therapeutic claims, and some whitening or anti-acne actives, can also fall outside the cosmetic definition in a given market. Confirm the classification before anything else — it determines whether the rest of this article even applies.
- The claims did not travel. A claim printed legally at home may need substantiation you do not hold, or be prohibited outright. Claims are assessed against the destination market’s rules, and “the factory said we could” is not a defence.
- The file was never really complete. A distributor confirms “registration is in progress” while an RP quietly waits on three supplier declarations. Ask for the actual submission reference and the file’s outstanding-items list, in writing, monthly.
Before you sign anything, put these six questions to the factory and the distributor and keep the answers: Which markets have you already supplied, and can you name a product currently on sale there? Can you provide a full quantitative formula under a confidentiality agreement, and if not, will you disclose directly to a safety assessor? Do you hold current ISO 22716 certification, and what is its scope? Which of the required tests already exist for this formula, with report dates? Who will own the notification and the Product Information File? And what happens to the notification and the artwork if this relationship ends? Vague answers here predict exactly the problems above. If the answers are weak, it is reasonable to run a parallel conversation with an alternative supplier — the approach in our guidance on vetting an overseas cosmetics manufacturer applies equally when you are re-qualifying an existing partner for export.
Frequently asked questions
Can I use my EU notification to sell in the UK as well?
No. Since the UK left the EU cosmetics regime, Great Britain operates its own Submit Cosmetic Product Notifications service and requires a Responsible Person established in the UK, so a product already notified in CPNP must be notified again for GB and carry a UK address on the pack. Northern Ireland continues to follow the EU rules. Budget for two representatives and two notifications if you want both territories, and design the label with room for both addresses.
Do I need a Responsible Person if I only sell online to EU customers?
Yes in practice. Making a cosmetic available to consumers in the EU market is what triggers the requirement, and selling directly to EU consumers online does not exempt the product from notification, the safety report or the Responsible Person obligation. Enforcement reaches marketplaces and customs as well as physical retail. If you are testing demand, do it through samples and pre-orders rather than by shipping unnotified stock.
Does my factory’s certificate of analysis count as a safety assessment?
No. A certificate of analysis confirms that a specific batch met its specification; a Cosmetic Product Safety Report is a toxicological assessment of the finished product, signed by a suitably qualified assessor, covering exposure, impurities, packaging interaction and microbiological quality. The two documents answer different questions and the EU and UK both require the second one before the product is placed on the market. Read our explainer on the safety report before accepting any substitute.
How long before a launch should I start the market-entry work?
Start six to nine months before your intended launch date if any of the required testing is missing, and three to four months if the full file already exists. The regulator’s part is rarely the delay; assembling supplier declarations, waiting on a challenge test and cycling artwork approvals is. Work backwards from the print deadline for your packaging, because that is the date that cannot move once plates are cut.
Sources and limitations
Regulatory positions in this article are drawn from primary sources: the European Commission’s cosmetics legislation portal for Regulation (EC) No 1223/2009, the CosIng ingredient database, the Cosmetic Product Notification Portal, the UK Cosmetic Products Enforcement Regulations 2013 and the Submit Cosmetic Product Notifications service, the US FDA’s pages on the Modernization of Cosmetics Regulation Act of 2022, facility registration and product listing and the Cosmetics Labeling Guide, and the Health Sciences Authority of Singapore’s summary of the ASEAN Cosmetic Directive. Standards referenced are ISO 22716 for cosmetics GMP and ISO 11930 for preservation efficacy.
Limitations. The cost ranges and elapsed times in this article are illustrative planning figures based on ordinary private-label projects, not surveyed data, and individual quotations vary widely by product complexity, existing test coverage and provider. Requirements are summarised at a level useful for planning; the detailed obligations for a specific product depend on its category, claims and formula, and rules change. We did not audit any manufacturer, laboratory or service provider in preparing this guide, and no market-entry pathway described here should be treated as a substitute for advice on your specific product. Verify current requirements against the primary sources linked above, or with a qualified safety assessor or regulatory consultant in the destination market, before committing budget. Last reviewed 24 August 2026.
This guide is general information for brand owners, not legal or regulatory advice. Requirements differ by product category, claim and jurisdiction, and change over time — confirm your own product’s position with the relevant authority or a qualified adviser before placing it on any market.